SkinbiotherapeuticsSBTX 
$0.13-0.94%24h
-0.94%24h
Global rank
Market cap$21.79M
Change 7d-16.63%
YTD Performance-30.98%
SP500 benchmarkUnderperform
P/E-7.69
P/S131.28
Revenue$165.97K
Earnings-$3.56M
Dividend yield-
Main Sector
Healthcare
Category
Skinbiotherapeutics (SBTX) Cash on Hand
SBTX Cash on Hand in 2022: $1.65M
According to Skinbiotherapeutics latest financial reports the cash on hand of SBTX is $1.65M, an decrease of -27.32% to 2022. At the end of 2022 company had $2.27M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
SBTX Cash on Hand History from 2019 to 2023
-
Value:-
SBTX Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $1.65M | -27.32% |
| 2022 | $2.27M | -60.85% |
| 2021 | $5.79M | 113.51% |
| 2020 | $2.71M | -30.91% |
| 2019 | $3.93M | - |
View the Top Cash on Hand Companies 
